Surfing the MASH Tsunami
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
- Update frequency
- every day
- Average duration
- 26 minutes
- Episodes
- 1069
- Years Active
- 2020 - 2025
S2-E34 - #ILC2021 Day Three - Multi-Disciplinary NAFLD Thinking, with Exciting Drugs on the Horizon
Manal Abdelmalek, Ian Rowe and first-timer Ken Cusi join Louise Campbell and Roger Green to review a thought-provoking, assumption-challenging Day Three of #ILC2021.
Most of the presenta…
S2-E33 - #ILC2021 Day Two -- Learning About Patients Through Large Databases
Jörn Schattenberg, Naim Alkhouri, Dr. Michelle Long of Boston University and Livia Alimena of the Global Liver Institute join Roger to review highlights of Day Two at ILC2021.
Each panel…
S2-E32 - Leaders Provide Perspectives on #ILC2021
Incoming EASL Secretary General Prof. Thomas Berg, Global Liver Institute President and CEO Donna Cryer and Genfit Head of Global Diagnostics Suneil Hosmane share their unique perspecti…
S2-E31.3 - Previewing Digital ILC 2021 -- Part II -- NITs, late-breakers and intriguing topics
Jörn Schattenberg, Stephen Harrison, Louise Campbell and Roger Green identify specific sessions and presentations they believe will bring the greatest enlightenment around tough challen…
S2-E31.2 - Previewing Digital ILC 2021 -- Part II -- Drug Development
Stephen Harrison and Jörn Schattenberg discuss what the titles of Digital ILC 2021 presentations tell us about possible findings in drug development.
Drug development presentations will…
S2-E31.1 - Previewing Digital ILC 2021 -- Part II -- "Favorite Things" and Discussing Metabolic issues
Jörn Schattenberg and the regular Surfers identify one thing about the Digital ILC 2021 meeting they anticipate eagerly and fall into a discussion about pharmacologic and non-pharmacolo…
S2-E31 - DIgital ILC 2021 -- Preview II
Joern Schattenberg joins the Surfers to identify exciting presentations and sessions from the Digital ILC 2021 meeting.
Digital ILC 2021 kicks off one week from today, with four days o…
S2-E30.3 - The Global Liver institute US NASH Action Plan - treatment and health system challenges
Global Liver Institute Director of Global Policy Andrew Scott, Madrigal Pharmaceuticals Co-Founder and CMO Becky Taub, and Central Virginia VA Health Care System Chief of Hepatology and…
S2-E30.2 - The Global Liver Institute US NASH Action Plan - Common, Reliable Diagnostics Are Critical
Global Liver Institute Director of Global Policy Andrew Scott, Madrigal Pharmaceuticals Co-Founder and CMO Becky Taub, and Central Virginia VA Health Care System Chief of Hepatology and…
S2-E30.1 - The Global Liver Institute US NASH Action Plan - Overview And What Education Must Achieve
Global Liver Institute Director of Global Policy Andrew Scott, Madrigal Pharmaceuticals Co-Founder and CMO Becky Taub, and Central Virginia VA Health Care System Chief of Hepatology and…
S2-E30 - The Global Liver institute US NASH Action Plan - What It Is and How We All Can Help Support it
Global Liver Institute Director of Global Policy Andrew Scott walks a diverse set of stakeholders through the US NASH Action Plan, with special focus on education, awareness and clarity…
S2-E29.3 - Previewing Digital ILC 2021 -- Part 1 -- What might emerge?
EASL Scientific Committee member Luca Valenti joins the Surfers to "crystal ball" potential key outcomes from Digital ILC 2021.
The four panelists each predict one likely outcome from Di…
S2-E29.2 - Previewing Digital ILC 2021 -- Part 1 -- Interests and Issues
EASL Scientific Committee member Luca Valenti joins the Surfers to discuss some of the issues that will be discussed at Digital ILC 2021.
After Luca and Stephen Harrison discuss what the…
S2-E29.1 - Previewing Digital ILC 2021 -- Part 1 -- Meeting Overview
Stephen Harrison and EASL Scientific Committee member Luca Valenti Preview Highlights of the Digital ILC 2021.
Luca and Stephen discuss what each of them consider highlights of this mont…
S2-E29 - Previewing Digital ILC 2021 -- Part 1
EASL Scientific Organizing Committee member Prof. Luca Valenti joins the Surfers to discuss some of the major NAFLD-related topics we will learn more about at Digital ILC 2021.
This epis…
S2-E27.2 - A Deeper Look At International NASH Day 2021 -- Activities, Future Plans, And Global Liver Institute Growth
Global Liver Institute President and CEO Donna Cryer joins the Surfers to discuss International NASH Day 2021. This conversation takes a deeper look at NASH Day and also Global Liver In…
S2-E27.1 - previewing International nASH day 2021 -- overview of events
Global Liver Institute President and CEO Donna Cryer joins the Surfers to discuss International NASH Day 2021. This conversation provides and overview of the day's event.
The 4th annual …
S2 - E28 - SPECIAL EPISODE: What Can We Learn The Aldafermin Discontinuation In F2/F3 NASH?
Roger Green narrates a series of interviews, conversations and viewpoints about NGM Biopharmaceuticals discontinuing its F2/F3 aldafermin program
The SurfingNASH team weaves interviews, …
S2-E27 - Previewing International NASH Day -- a growing Day of Global Education and Organizing
Global Liver Institute President and CEO Donna Cryer joins the Surfers to discuss International NASH Day 2021. Last year's IND had 100+ participants. This year will be bigger! Learn why…
S2-E26.3 - How much will real-life NASH treatment decisions depend on the specialty of the prescriber?
azen Noureddin returns to discuss the roles different drugs and drug classes will play in NASH therapy after current Phase 2b and Phase 3 candidates have been approved. This conversatio…